Comparison of these groups revealed substantially higher proportions of total CD8+ TILs among all tumor-infiltrating immune cells in pTRT cell-high BrM than in pTRT cell-low BrM or gliomas (Fig. 3e, left). This evidence concerns the gene CD8A and central nervous system cancer.